Get started
Author

Fabio Castiglioni

Observed names: Castiglioni, Fabio, F Castiglioni, F. Castiglioni
ORCID: 0000-0002-0944-3014
Observed ORCID: 0000-0002-0944-3014
OpenAlex ID: A5048908496
Pilot Study of the Mechanism of Action of Preoperative Trastuzumab in Patients with Primary Operable Breast Tumors Overexpressing HER2
2004 · Roberto Gennari, Sylvie Menard, et al. · Clinical Cancer Research · 515
PDF
Cell Motility Is Controlled by SF2/ASF through Alternative Splicing of the Ron Protooncogene
2005 · Claudia Ghigna, Silvia Giordano, et al. · Molecular Cell · 387
PDF
HER2 as a Prognostic Factor in Breast Cancer
2001 · Sylvie Ménard, Stefania Fortis, et al. · Oncology · 267
Tumor-Initiating Cells of HER2-Positive Carcinoma Cell Lines Express the Highest Oncoprotein Levels and Are Sensitive to Trastuzumab
2009 · Alessandra Magnifico, Luisa Albano, et al. · Clinical Cancer Research · 251
Visible-Light-Driven Rotation of Molecular Motors in a Dual-Function Metal–Organic Framework Enabled by Energy Transfer
2020 · Wojciech Danowski, Fabio Castiglioni, et al. · Journal of the American Chemical Society · 157
Role of exon-16-deleted HER2 in breast carcinomas
2006 · F Castiglioni, E Tagliabue, et al. · Endocrine Related Cancer · 146
Modulation of porosity in a solid material enabled by bulk photoisomerization of an overcrowded alkene
2020 · Fabio Castiglioni, Wojciech Danowski, et al. · Nature Chemistry · 93
PDF
Identification of a novel function for 67-kDa laminin receptor: increase in laminin degradation rate and release of motility fragments.
2002 · Elena Ardini, Barbara Sporchia, et al. · PubMed · 80
Radiation Effects on Development of HER2-Positive Breast Carcinomas
2007 · Fabio Castiglioni, Monica Terenziani, et al. · Clinical Cancer Research · 70
Regulation of Breast Cancer Response to Chemotherapy by Fibulin-1
2007 · Serenella M. Pupa, Sarah Giuffré, et al. · Cancer Research · 69
Nerve Growth Factor Cooperates with p185 in Activating Growth of Human Breast Carcinoma Cells
2000 · Elda Tagliabue, Fabio Castiglioni, et al. · Journal of Biological Chemistry · 63
PDF
Ultrafast Molecular Rotors and Their CO 2 Tuning in MOFs with Rod‐Like Ligands
2017 · Silvia Bracco, Fabio Castiglioni, et al. · Chemistry - A European Journal · 57
PDF
Identification of Breast Cancer-Restricted Antigens by Antibody Screening of SKBR3 cDNA Library Using a Preselected Patient's Serum
2002 · Stefania Forti, Matthew J. Scanlan, et al. · Breast Cancer Research and Treatment · 55
Fluorinated porous organic frameworks for improved CO 2 and CH 4 capture
2019 · A. Comotti, F. Castiglioni, et al. · Chemical Communications · 52
Biology, prognosis and response to therapy of breast carcinomas according to HER2 score
2008 · S. Ménard, A. Balsari, et al. · Annals of Oncology · 35
PDF
The crystal structure of a new calcium aluminate phase containing formate
2021 · Maria Chiara Dalconi, Gilberto Artioli, et al. · Cement and Concrete Research · 21
A new multifunctional additive for blended cements
2022 · Giorgio Ferrari, Alberto Brocchi, et al. · Construction and Building Materials · 14
Production of a Monoclonal Antibody Directed against the High-Affinity Nerve Growth Factor Receptor
1999 · E. Tagliabue, C. Ghirelli, et al. · The International Journal of Biological Markers · 8
Low Carbon Concrete Admixtures. A New Class of Products for Concrete Net Zero 2050 Scenario
2024 · Giorgio Ferrari, Fabio Castiglioni, et al. · Rilem bookseries · 4
An Insight into the Mechanism of Hydration Promotion of Low Carbon Concrete Admixtures Revealed by a Multidisciplinary Approach
2024 · Fabio Castiglioni, Gilberto Artioli, et al. · Rilem bookseries · 2
A Chemometric Approach for the Optimization of Low Carbon Concrete Admixtures with Blended Cements
2024 · Clelia Sarta, Alexandre Agha Ghassem, et al. · Rilem bookseries · 2
Frontispiece: Ultrafast Molecular Rotors and Their CO2 Tuning in MOFs with Rod‐Like Ligands
2017 · Silvia Bracco, Fabio Castiglioni, et al. · Chemistry - A European Journal · 1
Supplementary Figures S1-S6 from Tumor-Initiating Cells of HER2-Positive Carcinoma Cell Lines Express the Highest Oncoprotein Levels and Are Sensitive to Trastuzumab
2023 · Alessandra Magnifico, Luisa Albano, et al.
PDF
Translation on this Article from Tumor-Initiating Cells of HER2-Positive Carcinoma Cell Lines Express the Highest Oncoprotein Levels and Are Sensitive to Trastuzumab
2023 · Alessandra Magnifico, Luisa Albano, et al.
Data from Tumor-Initiating Cells of HER2-Positive Carcinoma Cell Lines Express the Highest Oncoprotein Levels and Are Sensitive to Trastuzumab
2023 · Alessandra Magnifico, Luisa Albano, et al.
Works count: 58
Citation count: 2,349
H-index: 16
I10-index: 17
Year
Topic
Type